Rare erythrocyte phenotypes: Clinical significance;Les phénotypes érythrocytaires rares: Importance clinique

Hematologie

Volumn 7, Issue 5, 2001, Pages 316-327

  Noizat Pirenne, F ^a   Le Pennec, P Y ^a   Ansart Pirenne, H ^a   Rouger, P ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

FY blood group; Newborn hemolytic; Rare erythrocyte phenotypes; RH blood group; Sickle cell disease

Indexed keywords

ANTIBODY;

BLOOD TRANSFUSION; DIFFERENTIAL DIAGNOSIS; DOCTOR PATIENT RELATION; ERYTHROCYTE; ETHNIC DIFFERENCE; HUMAN; MEDICAL DECISION MAKING; PHENOTYPE; PHYSICIAN ATTITUDE; PREGNANCY; PROTEIN EXPRESSION; SHORT SURVEY; SICKLE CELL ANEMIA; TREATMENT INDICATION; TREATMENT PLANNING; VASCULARIZATION;

EID: 0035657242     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (36)

1. Nomenclature des antigènes et groupes sanguins
2. International society of blood transfusion working party on terminology for red cell surface antigens
3. Arrêté du 28 décembre 1995 relatif aux conditions d'utilisation des prélèvements de sang ou de composants du sang correspondant à des groupes sanguins érythrocylaires rares
4. Immunology of red cell
5. Antibody detection and identification and compatibility testing
6. Race-related red cell alloantibody problems
7. Usefulness of the effect of different enzymes on antigens in antibody identification
8. Les contrôles de lots de réactifs au centre national de référence des groupes sanguins. Données de l'année 1998
9. Clinical significance of some alloantibodies to blood group antigens
10. Sécurité transfusionnelle: Risques émergents ou hypothétiques
11. Transfusion-associated graft-versus-host disease
12. Virus et ATNC: Le point sur la transmission par le sang
13. Comportement à risque chez les donneurs de sang: Efficacité d'un nouveau questionnaire
14. Current issues with blood transfusions in sickle cell disease
15. Transfusion des patients atteints d'hémoglobinopathies
16. Antigen-negative incidence for common polymorphic antigens
17. Bone marrow transplantation in sickle cell anemia
18. Drépanocytaire homozygote en « impasse transfusionnelle » évolution favorable sous hydroxyurée
19. Potential alternatives to erythrocyte transfusion in hemoglobinopathies: Hydroxyurea (HU), erythropoietin (EPO), butyrate derivatives, blood substitutes
20. Molecular basis and structure-activity relationships of the Duffy blood group antigens chemokine and plasmodium vivax receptor
21. Characterization of antibodies produced by S-s- individuals
22. An invited review: The Rh antigene, its variants, and some closely related serological observations
23. N phenotypes
24. s negative African Blacks: Molecular background and transfusion safety
25. Graft rejection and second bone marrow transplant for acute aplastic anaemia: A report from the Aplastic Anaemia World Party of the European Bone Marrow Transplant Group
26. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis
27. Successful delivery of a baby from a D-mother with a potent anti-RH17
28. Functional aspects of red cell antigens
29. Molecular basis of red cell protein antigen deficiencies
30. RH blood group system and molecular basis of Rh-deficiency
31. Kell, Kx and the McLeod syndrome
32. Analysis of deletions in three McLeod patients: Exclusion of locus from the Xp21.1-Xp21.2 region
33. The Duffy protein: A malarial and chemokine receptor